Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.

For decades, KRAS, one of the deadliest cancer-causing mutant proteins, has been considered impossible to target due to its ...

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes-insights that could help doctors ...

Some 17 million Americans are living with genetic mutations tied to an increased risk of getting cancer, Cleveland Clinic researchers warned Monday. And the more than 3,400 mutations identified – ...

Researchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every possible mutation in a critical hotspot, they found that ...

Carbone called BAP1 a “paradox” because of its seeming ability to both promote and slow cancer, depending on the ...

Mutations in a protein called KRAS fuel some of the most lethal cancers. Designing drugs to disable KRAS has proved ...

The U.S. Food and Drug Administration (FDA) has granted plixorafenib a Breakthrough Therapy Designation, signaling ...

Leah Phillips was diagnosed with Stage 4 lung cancer at 43. She never smoked, but a genetic mutation allowed the cancer to ...

Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.

Sperm from a single donor in Europe has reportedly been used to conceive at least 67 pregnancies, although the donor carried a rare cancer-causing mutation. The donor’s mutation has been linked to ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...